PUR fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Pure Biologics SA engages in the research and development of biological drug and non-systemic therapies. It focuses on immuno-oncology, autoimmunology, and rare neurological diseases. The company was founded by Filip Jan Jelen, Maciej Piotr Mazurek, Piotr Jan Jakimowicz, Jacek Józef Otlewski, and Andrzej Jan Trznade and in 2010 and is headquartered in Wroclaw, Poland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
PUR does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company